β-1,3 Glucan Microparticles & Nanoparticles: Fabrication Methods & Applications in Immunomodulation & Targeted Drug Delivery.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40302314.
- Also identified by DOI 10.1002/adhm.202501006 and PMC identifier 12118341.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Innate immune cells such as macrophages and dendritic cells play major roles in the progression of many cancerous, fibrotic, and autoimmune diseases, often due to environmental cues that skew these cells toward a phenotype that progresses or exacerbates the disease state. As such, a growing focus in treating such diseases is placed on exploiting the high plasticity of these cells to modify or reverse their pro-disease phenotypes using immunomodulatory materials. β-1,3 glucans are one such type of material that has exhibited diverse immunomodulatory effects on immune cells, including the mitigation or reversal of the adverse effects of dysregulated immune cells. In this review, we outline various fabrication techniques to produce β-1,3 glucan-derived microparticles and nanoparticles and discuss the diverse particle properties that can be obtained by tuning glucan chemistry, fabrication method, and formulation components. Furthermore, the immunomodulatory applications of β-1,3 glucan particles are highlighted with a focus on immune cell targeting, modulation, and the delivery of small molecule and macromolecular therapeutics.
Medical subject headings
- beta-Glucans
- Nanoparticles
- Immunomodulation
- Drug Delivery Systems